Febrile Neutropenia, Drug-Induced

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Febrile Neutropenia, Drug-Induced trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT06616571

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

The goal of this real-world study is to compare the efficacy and safety of QL0605 administered 24 hours and 48 hours after chemotherapy in breast cancer patient…

China336 participantsStarted 2024-09-19

Treatment: QL0605(PEG-rhG-CSF), QL0605(PEG-rhG-CSF)

All recent trials (19 shown)

Active — Not RecruitingPhase 3

NCT06711523

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

To evaluate the efficacy, safety, and immunogenicity of PEG-G-CSF Injection (Kexing Biopharmaceutical Co., Ltd.) for the prevention of neutropenia after chemoth…

China250 participantsStarted 2025-01-09

Treatment: PEG-G-CSF injection (Kexing Biopharmaceutical Co., Ltd.), PEG-G-CSF injection (Neulasta®，Amgen Europe B.V.)

Not Yet RecruitingPhase 4

NCT06988826

Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile Neutropenia

This study aim to find the best option for children having cancer who develop low immunity state due to chemotherapy

Location not specified150 participantsStarted 2025-06-01

Treatment: G-CSF, Antibiotics only

Febrile Neutropenia, Drug-Induced

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

All recent trials (19 shown)

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile Neutropenia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

All recent trials (19 shown)

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile Neutropenia

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim

Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department fo…

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early War…

Efficacy and Safety Study With MYL-1401H and Neulasta

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer

A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia

Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia

Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and N…

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Admin…

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granuloc…

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy